video sobre la investigación en laboratorios

Cancer Innova Program

CANCER INNOVA is the first initiative framed in the new Business Factory Medicines de Galicia. The Kærtor Foundation and the Scientific Foundation of the Spanish Association Against Cancer, in collaboration with the Galician Innovation Agency (GAIN), and the pharmaceutical companies Janssen, of the Johnson & Johnson group, and Lilly have created the CANCER INNOVA Program for the development of new drugs against cancer and for the consolidation of a biotechnological ecosystem close to patients. The imminent incorporation of a second multinational pharmaceutical company is expected. submit your proposal more info partners
imagen de muestras en laboratorio

Cancer Innova: Towards Innovation in Cancer

Collaboration to support innovation in cancer and accelerate the translation of research to patients.

The Cancer Innova Program (CIP) is an inclusive collaboration in which public and private entities jointly participate to promote innovation in cancer. To this end, a drug discovery program has been created aligned with the Cancer Mission of the Horizon Europe framework program, which represents a landmark in the biotechnology sector.

imagen de muestras en laboratorio
imagen de muestras en laboratorio

Accelerating drug discovery in cancer

This project is part of the Business Factory model of the Government of Galicia. Its seed was the I2D2 program, a collaboration between GAIN, Kaertor Foundation and Janssen/ J&J, which incubated early research projects in new drug discovery and validated a new incubation methodology based in five validated work packages. This resulted in an 80% reduction of time and costs, compared to the industry averages.

In the Cancer Innova program, application of the most disruptive research of the highest scientific quality on cancer will be carried out, with the aim of achieving proof of concept in humans through research planned by milestones.

imagen de muestras en laboratorio

Who is the Cancer Innova program aimed at?

The CIP program is aimed towards researchers and public or private entities as well as small companies specialized in cancer mechanisms who want to apply their research to drug discovery.

imagen de muestras en laboratorio

Project stages

Click on each of the phases to have more information.

01.

Call & selection.
Call and EOI selection

02.

Incubation.
Signing of agreements and incubation

03. & 04.

Acceleration & Consolidation.
Transfer of projects to the market

Expression of Interest form

The first selected projects to start the incubation phase will be chosen from the Expressions of Interest (EoI) received by the first two evaluation deadlines (on 21st December 2020 and on 31st January 2021 at 15:00 (CET)) although the call for proposals will remain open in the Cancer Innova website and projects received after these dates will continue to be considered.

Project carried out by:

Gain
Asociación Española Contra el Cancer
Fundación Kaertor
Janssen
Lilly